On May, 2014, two more ELISA kits manufactured by Alkor Bio – “ToxoplasmaEIA IgG” kit for qualitative and quantitative detection of immunoglobulins G  to Toxoplasma gondii and  “ToxoplasmaEIA IgG Avidity” kit for detection of immunoglobulins G avidity to Toxoplasma gondii in the human blood serum and plasma – have received CE-mark. 

At the end of May the Alkor Bio Group, one of the leading Russian developers and manufacturers of laboratory test kits, started producing 15 new allergens. All allergens are aimed to be used together with “AllergoEIA-specific IgE” kit by Alkor Bio Group - allergy diagnostics test-system for specific IgE determination in human blood serum by means of ELISA method.

Alkor Bio Group informs you about the release of 17 new allergens  and mixes of allergens for the «AllergoEIA-specific IgE» kit.

Microarrays    Tecan journal 1/2014   

Alkor Bio has developed a rapid and accurate microarray-based diagnostic assay for cystic fibrosis using Tecan’s HS 400™ Pro Hybridization Station and PowerScanner™, allowing one technician to screen 10 patients for 25 cystic fibrosis mutations in under seven hours.

Alkor Bio Group, one of the leading Russian developers and manufacturers of laboratory ELISA kits, started producing local anesthetics allergens for the kit AllergoEIA-specific IgE. Early February Alkor Bio Group has issued 13 new allergens, including local anesthetics allergens Ultracaine, Lidocaine, Benzocaine, Novocaine.

Sequoia genetics has received European CE Mark approval for next-generation sequencing solution for diagnostics of inherited diseases in newborns. The company got official notification from MediMark Europe at the end of 2013. Thus the solution named VariFind Neonatal assay is approved for in vitro diagnostics in European Economic Area.